课题基金 / 基金详情

Study for Extensive Application of Salvaging Autotransfusion

Study for Extensive Application of Salvaging Autotransfusion
挽救性自体输血的广泛应用研究
批准号:
01480380
负责人:
TAKAORI Masuhiko
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1991

项目摘要

项目成果

TAKAORI Masuhiko的其他基金

相关文献

中文摘要
翻译
研究一:将丝裂霉素C以5个浓度的15种组合作用于多种肿瘤细胞,暴露时间为3个,确定了抑制肿瘤细胞植入完整动物体内的最低暴露条件。对Ehrlich‘腹水瘤(EL-BP-3)的最低暴露条件为(1)100 mg/ml作用15分钟,(2)对Harding-Passey黑色素瘤作用15分钟,(3)对AH-66或AH-130大鼠肝癌作用20分钟。研究2:钙拮抗剂对抑制作用的相加作用。在研究1中获得的移植中,维拉帕米加入丝裂霉素C,使艾氏腹水瘤的最低丝裂霉素C浓度从100降至50微克/毫升,作用15分钟,但对Harding-Passey黑色素瘤无影响。研究3:其他抗癌药物的抑制作用。在BDF小鼠体内检测阿霉素、色霉素、阿克拉阿霉素和卡介苗对Harding-Passey黑色素瘤细胞移植的抑制作用。最低暴露浓度分别为:阿霉素10 mg/ml作用20分钟,色霉素500 mg/ml作用15分钟,阿克拉霉素1 mg/ml作用20分钟。即使当浓度增加到可溶的限度时,卡酚仍无任何作用。这一结果鼓励我们在手术中可以使用挽救的自体输血来切除恶性肿瘤,而红细胞则应用抗癌药物处理。
英文摘要
Study 1 : Various malignant cells were exposed to mitomycin C in vitro at 15 combinations of 5 concentrations and 3 exposure duration and minimum exposure condition which is capable to suppress implantation of tumor cells into intact animals was determined. The minimiim exposure condition was(1)100 mug/ml for 15 minutes against Ehrlich'ascites tumor(EL-BP-3), (2)400 mug/ml for 15 minutes against Harding-Passey melanoma, (3)100 mug/ml for 20 minutes against either AH-66 or AH-130 rat hepatoma.Study 2 : Additive effect of Ca-antagonist to the suppressive effects. in transplantation obtained in Study 1. Verapamil of 10 muM/ml added to mitomycin C decreased the minimum concentration of mitomycin C from 100 to 50 mug/ml for 15 minutes for Ehrlich'ascites tumor but not Harding-Passey melanoma. None of the additive effect was noted with nicardipine(at 10 - 100 muM/ml)for the tested tumor either.Study 3 : Suppressive effects of other anticancer drugs.The suppressive effects on the implantation of Harding-Passey melanoma cells with doxorubicin, chromomycin, aclarubicin and carboquone were tested in BDF mice. The minimum exposure concentration was 10 mg/ml for 20 minutes with doxorubicin, 500 mug/ml for 15 minutes with chromomycin and 1 mg/ml for 20 minutes with aclarubicin. None of the effect was noted with carboquone even when the concentration was increased up to the solvable limit of carboquone.These results encouraged us that salvaging autotransfusion could be used during operation for removal of malignant tumor, whereas the red cells should be treated with the anticancer drug.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
福井明,高折益彦: "回収式自己血輸血の改良点" 日本輸血学会雑誌. 35. 717-720 (1989)
Akira Fukui、Masahiko Takaori:“恢复性自体输血的改进”日本输血学会杂志 35. 717-720 (1989)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
福井 明,吉田 仁,大隅 昭幸,藤田 喜久,高折 益彦,難波 正義: "回収式自己血輸血における悪性腫瘍細胞除去に関する研究:各種抗腫瘍薬の比較" 日本輸血学会雑誌.
Akira Fukui、Hitoshi Yoshida、Akiyuki Osumi、Yoshihisa Fujita、Masuhiko Takaori、Masayoshi Namba:“在回收的自体输血中去除恶性肿瘤细胞的研究:各种抗肿瘤药物的比较”日本输血学会杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
福井 明 他: "回収式自己血輸血における悪性腫瘍除去に関する研究(2)" 日本輸血学会雑誌. 37. (1991)
Akira Fukui等:“回收自体输血中恶性肿瘤去除的研究(2)”日本输血学会杂志37。(1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fukui Akira, Kimura Kenichi, Takaori Masuhiko: "Study on elimation of malignant cell from red cell concentration during salvaging autotransfusion - Effect of mitomycin C" Japanese Journal of Transfusion Medicine.
Fukui Akira、Kimura Kenichi、Takaori Masuhiko:“挽救性自体输血期间红细胞浓度消除恶性细胞的研究 - 丝裂霉素 C 的作用”日本输血医学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 18 条
    Effect of positive end-expiratory pressure ventidation on organ blood volumes
    • 批准号:
      04454397
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $3.46万
    • 财政年份:
      1992
    • 负责人:
      TAKAORI Masuhiko
    • 依托单位: